Recursion Pharmaceuticals has reported updated data from its ELUCIDATE & TUPELO trials, but the stock has failed to mount a ...
Key Takeaways Supreme Court to decide if “generic version” marketing can support induced infringement claims. On Jan. 16, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback